Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
XI'AN HAIXIN Pharmaceutical Co., Ltd.
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Yangtze River Pharmaceutical (Group) Co., Ltd.
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Hainan Tongyong Kangli Pharmaceutical Co., Ltd.
Nimustine Hydrochloride for Injection
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Shendan Sanjie Capsules
Manufacturer:
STAR Pharmaceutical Pte.ltd
Shendan Huoxue Capsule
Manufacturer:
Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory
Xiaoaiping Capsules
Manufacturer:
Nanjing Zhongshan Pharmaceutical Co., Ltd.
Related Ingredients
-
Nimustine hydrochloride list
55661-38-6 -
1,10-Phenanthroline hydrate list
5144-89-8